Individual drug treatment in a mouse model of JMML equally ameliorates monocytosis and splenomegaly but combined treatment uniquely ameliorates thrombocytopenia. Overall design: To elucidate the gene expression changes impacted on BTK and PI3K-P110δ treatment in Shp2 E76K mice